Financial Structure

Prior to 2007 Synexus was listed on the London Stock Exchange’s AIM. Following acceptance of a cash offer Synexus delisted. Synexus is now financed through a combination of private equity and management ownership. The new financial structure and continuing investment best supports the growth momentum of the business.

Latest news

Synexus® doubles turnover and triples forward orders

Synexus®, a world leader in the recruitment and running of clinical trials, increased its turnover by more than fifty percent in the first half of the year to more than $30million.

Visit our patients site

At Synexus we produce great results. For our clients, the pharmaceutical companies we partner, the healthcare professionals and of course, for our patients.

About Synexus

Financial Structure